Beryl Drugs Limited (BSE: 524606)
Health Care · Pharmaceuticals · IN
Rs26.31
+4.03% today · +12.0% 1Y
Beryl Drugs Limited (BSE: 524606) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.38M.
Over the last twelve months the share price has gained 12.0%, trading between 15.92 and 27.60.
Tweenvest scores Beryl Drugs Limited across four factors: quality 63/100, value 49/100, growth 0/100. Its strongest factor is quality.
524606 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.38M
- Revenue (TTM)
- $2.26M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.16
- 52-week high
- Rs27.60
- 52-week low
- Rs15.92
- Avg volume (3M)
- —
- Shares outstanding
- 5.07M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Gabather AB (publ)OM: GABA | $1.47M | Skr0.02 | -16.67% |
| Avenue Therapeutics, Inc.OTCPK: ATXI | $1.42M | $0.43 | +5.45% |
| CannaPharmaRX, Inc.OTCPK: CPMD | $1.40M | $0.00 | -16.67% |
| Akanda Corp.NasdaqCM: AKAN | $1.38M | $1.71 | -2.84% |
| CBD Life Sciences Inc.OTCPK: CBDL | $1.27M | $0.00 | +100.00% |
| Nascent Pharma Holdings, Inc.OTCPK: NASC | $1.25M | $0.01 | -4.60% |
| Labocanna S.A.WSE: LCN | $1.21M | zł0.22 | +4.67% |
| Emmessar Biotech & Nutrition LimitedBSE: 524768 | $1.17M | Rs22.59 | -1.74% |
Figures last refreshed Oct 11, 2026.